Calamos Advisors »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Calamos Advisors

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $74k 50k 1.47

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Wolverine Asset Management
Readystate Asset Management
MacKay Shields
Franklin Resources
Point72 Asset Management
SSI Investment Management
Advent Capital Management
Lazard Asset Management
Bnp Paribas Arbitrage, Snc
BlackRock
BlackRock
Nicholas Investments Partners
Bank of America Corporation
Kornitzer Capital Management

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0